Comparative Evidence Needs Earlier Consideration In Drug Development Process – Novartis Exec
Executive Summary
As comparative effectiveness research grows in importance, drug manufacturers need to factor it, as well as payer evidence needs, into product development decisions, Novartis Head of Comparative Effectiveness Research and Communications Amy Rudolph says.